Phase I Clinical Trial For An H5N1 Bird Flu Vaccine Shows Positive Results
IDRI (Infectious Disease Research Institute), a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today reported positive interim results from a Phase I clinical trial for an H5N1 Avian Influenza VLP vaccine candidate ("H5N1 vaccine")...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Bird Flu / Avian Flu Source Type: news
More News: Bird Flu | Bird Flu (H5N1 Avian Influenza) Vaccine | Clinical Trials | H5N1 | Health | Infectious Diseases | Influenza | Influenza Vaccine | Vaccines